ARCHIVES

Bristol-Myers Squibb Board Removes CEO Peter Dolan Over Plavix Deal. Two Republican Senators Say They Will Place Holds On Confirmation of Andrew von Eschenbach as FDA Commissioner. Craig Thompson Named Director of Abramson Cancer Center.

This article is from The Cancer Letter archive.

Vol. 32 No. 32 | September 15, 2006

Download PDF Visit The Full Archive

Related Articles

Regulatory Agencies: HCFA Proposes Physician Transfer Of Drug Discounts To Medicare, Insurers

April 3, 1998

HHS Names Crawford FDA Deputy Commissioner; Williams Appointed Deputy For Oncology Division.

March 1, 2002

“Cancer Is a Disappearing Disease” and Other Controversies

January 3, 1986

NCI Tightens Monitoring, Upgrades Staff Training In Attempts To Improve Management Of Contracts

January 9, 1981

Multiple Studies Show Benefit of CTL019, A Personalized Therapy, in CLL and ALL

December 27, 2013

House Overrides Veto Of Authorization Bill As GOP Members Join Democrats In Assailing Reagan Action

November 15, 1985